It's that time of the year again, when investors are rebalancing their portfolios and setting new strategies for the year ahead. We already dove into the best Dow Jones Industrial Average (DJI) and S&P 500 Index (SPX) stocks of 2025, but now it's time to talk about the elephant in the room: the underperformers.The worst performer on the Dow this year is UnitedHealth Group Inc (NYSE:UNH). The healthcare company has been mired in controversy since December 2024, following the murder of CEO Brian Thompson. A s ...

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. UnitedHealth has pledged to make a range of improvements in response to the first outside reviews of its business practices as the healthcare behemoth works to improve waning consumer trust. The independent analyses, completed by FTI Consulting and the Analysis Group in November and released on Friday, didn’t find a smoking gun that UnitedHealth is leveraging ...

UnitedHealth Group Incorporated (NYSE:UNH) is one of the most widely held stocks by hedge funds in 2025. Reuters reported on December 19 that UnitedHealth Group Incorporated (NYSE:UNH) announced on Friday that audits of its health services and pharmacy benefit units conducted by outside consulting firms would lead to operational changes, including increased automation and standardization of internal processes. UnitedHealth Exits South America With Banmedica Sale UnitedHealth Group Incorporated (NYSE:UNH) ...

High Income DIY Portfolios: The primary goal of "High Income DIY Portfolios" Marketplace service is high income with low risk and preservation of capital. It provides DIY investors with vital information and portfolio/asset allocation strategies to help create stable, long-term passive income with sustainable yields. The portfolios are designed for Income-Investors (including retirees or near-retirees). We provide seven portfolios: 3 buy-and-hold, 3 Rotational portfolios, and 3-Bucket NPP Model Portfolio. T ...

North America Equity Research December 2025 Healthcare Services 2026 Outlook: It's Different This Time: Potential for Margin Improvement and Policy Clarity Create a Positive Backdrop Conference Call Details Tuesday, December 17 @ 10:00am ET / 15:00 UK Dial-in Info: Please contact us or your JPM salesperson for details Replay Info: Available approximately 2-3 hours after the call ends Healthcare Services Lisa C. Gill AC (212) 622-6466 lisa.c.gill@jpmorgan.com Bloomberg JPMA GILL J.P. Morgan Securities LLC Ma ...

In this article, we will look at the 12 Most Widely Held Stocks by Hedge Funds in 2025.On December 17, Lori Calvasina, RBC Capital Markets head of U.S. equity strategy research, appeared on CNBC’s ‘Squawk Box’ to talk about expectations from markets and earnings in the coming year.She expects 2026 to be a good year, and added that she wishes the 5% drawdown we experienced a month or so ago had been a little more substantial to remove more froth, as there is still “a lot of angst” out there. Despite the need ...

智通财经APP获悉，美国总统唐纳德·特朗普表示，他将在未来几周召集美国众多医疗健康保险公司开 会，试图向这些公司施压，要求它们为将在年末奥巴马医改补贴到期后面临保费上涨的美国人降低医疗 健康保险成本。对于特朗普政府而言，补贴"悬崖"会直接触及数千万选民的账单，在生活成本敏感期极 易演变成对执政方不利的民意与选举议题，因此特朗普以"开会施压"抢占叙事主动权，塑造"正在解决 问题"的姿态，力争获得更多来自中低收入选民的信赖，进一步为2026年中期选举造势。 "我要召集保险公司开会，"特朗普当地时间周五在白宫对记者表示。"说得直白点，我会看看他们能不 能把价格全面降下来。" 特朗普称，这次会议可能将在下周举行，届时他将在佛罗里达州的海湖庄园度假;或在他返回华盛顿后 的1月第一周举行。他强调，这个想法是他当场想到的，当时他在一场重要活动中，他听到大型制药公 司高管们承诺将捐赠药品，作为一项避免特朗普政府关税协议的一部分。 在特朗普发表上述言论后，美国医疗健康保险行业领军者们，比如联合健康集团(UnitedHealth Group Inc.)、信诺集团(Cigna Group)以及哈门那公司(Humana Inc.)等 ...

Core Insights - President Trump announced a set of drug-pricing agreements with nine major pharmaceutical companies, aiming to align U.S. medicine costs with those in Europe [1][2] - The initiative includes a new direct-to-consumer portal, TrumpRx.gov, allowing patients to purchase certain medicines directly from manufacturers [2][4] Group 1: Agreements and Participants - The agreements involve 14 out of 17 drugmakers that Trump previously urged to lower prices, including Amgen, GSK, and Merck [2][3] - Drug companies are motivated to negotiate to avoid potential regulatory measures that could impact their profits [3] Group 2: TrumpRx.gov Functionality - TrumpRx.gov will serve as a central directory for patients to access selected medicines directly from manufacturers' websites [4] - The portal is expected to be fully operational by January, following a promotional launch [4] Group 3: Pricing Details - Highlighted medicines include Amgen's Repatha at $239/month, GSK's Advair Diskus at $89/month, and Merck's Januvia at $100/month [6] - Gilead's Epclusa will be priced at $2,492/month, despite lower costs for insured patients [6] Group 4: Impact on Medicaid and Medicare - Companies committed to launching new medicines in the U.S. at prices comparable to those in other wealthy countries [8] - Medicaid programs are legally entitled to the lowest drug prices, with Bristol Myers Squibb offering Eliquis free to Medicaid [9] Group 5: Industry Response and Future Outlook - Health policy experts express skepticism about the agreements' impact on overall drug prices for most Americans [10] - The agreements do not impose mandatory price controls and leave many brand-name drug costs unchanged [15] - Ongoing discussions with additional manufacturers like AbbVie and Johnson & Johnson may lead to further agreements [14]

UnitedHealth Group has laid off dozens of remote employees in healthcare technology and services marketing from its Optum unit, who were given two weeks notice in November, sources told Health Payer Specialist. Most Read from Fast Company Fast Company has reached out to UnitedHealth for confirmation. Those employees were based in “multiple states on the East Coast and in the Midwest,” according to that report, and are among UnitedHealth’s roughly 400,000 employees across the U.S. (It is the parent compa ...

在特朗普发表上述言论后，包括哈门那（Humana，HUM）、联合健康（UnitedHealthcare，UNH）、信 诺（Cigna，CI）、CVS健康（CVS Health，CVS）和Elevance Health（ELV）在内的股票，要么回吐涨 幅，要么进一步下跌。特朗普此番言论是在一场宣布与九家制药公司达成定价协议的新闻活动结束时作 出的。 "我将召集那些已经变得非常富有的大型保险公司开会，"特朗普表示，并指出他将游说它们降低价格。 "我想，也许只要谈一次，他们就愿意把价格削减50%、60%甚至70%。他们已经赚得盆满钵满。" 在特朗普发表上述言论后，包括哈门那（Humana，HUM）、联合健康（UnitedHealthcare，UNH）、信 诺（Cigna，CI）、CVS健康（CVS Health，CVS）和Elevance Health（ELV）在内的股票，要么回吐涨 幅，要么进一步下跌。特朗普此番言论是在一场宣布与九家制药公司达成定价协议的新闻活动结束时作 出的。 "我将召集那些已经变得非常富有的大型保险公司开会，"特朗普表示，并指出他将游说它们降低价格。 "我想，也许只要谈一次，他们就愿意把价格 ...